What do GLP-1 medications have to do with PCOS?

If you live with Polycystic Ovary Syndrome (PCOS), you’ve likely heard a lot about hormones, insulin resistance, and the challenges of managing weight. You may also be hearing more about GLP-1 medications, such as semaglutide and liraglutide, drugs that were first used for type 2 diabetes but are now being studied for their benefits in other metabolic conditions, including PCOS.

PCOS affects hormone balance, ovulation, and metabolism. One of the biggest factors connecting all of these pieces is insulin resistance, when the body doesn’t respond to insulin properly, causing higher insulin levels that, in turn, raise androgen (testosterone) production. This imbalance can lead to symptoms like irregular cycles, acne, and unwanted hair growth, while also increasing the risk for type 2 diabetes and heart disease.

So where do GLP-1 medications fit in?

Recent research shows that they may help improve several of the core metabolic and hormonal challenges associated with PCOS. Studies have found that women with PCOS and obesity who take GLP-1 medications often experience meaningful weight loss, smaller waist measurements, and lower triglycerides, all important markers for reducing long-term risk for diabetes and cardiovascular disease.

Beyond these metabolic benefits, GLP-1 medications may also influence hormone balance. Evidence suggests that they can help lower total testosterone levels, which may improve symptoms related to hyperandrogenism, such as acne and excess hair growth. By reducing insulin resistance and improving weight management, these medications appear to indirectly support more balanced hormone levels overall.

For insulin and blood sugar control, GLP-1 medications have been shown to support healthier glucose metabolism, especially when paired with other treatments like metformin or lifestyle changes. This combination not only helps with blood sugar regulation but also contributes to improvements in cholesterol levels and triglycerides, two markers that are closely linked to cardiovascular health in women with PCOS.

While these findings are promising, it’s important to remember that GLP-1 medications work best when combined with sustainable nutrition and lifestyle habits. Balanced meals that include protein, fiber, and hydration are essential for maintaining energy, muscle mass, and gut health. Physical activity, adequate sleep, and stress management also continue to play major roles in long-term hormonal balance.

GLP-1 therapy is not a replacement for these habits, but it can be a helpful tool for managing some of the underlying drivers of PCOS, including insulin resistance and elevated androgens. For women struggling with weight management, metabolic symptoms, or hormone-related changes, it may offer another pathway toward feeling more balanced and in control of their health.

To learn more about how GLP-1 medications affect digestion, appetite, and nutrition, and how to manage these side effects, see the previous post on nutrition strategies for GLP-1 users.

References:

Bo, Y., Zhao, J., Liu, C., & Yu, T. (2025). Comparative efficacy of pharmacological interventions on metabolic and hormonal outcomes in women with polycystic ovary syndrome: A network meta-analysis of randomized controlled trials. BMC Women’s Health, 25, 64. https://doi.org/10.1186/s12905-025-03594-6

De Hollanda Morais, B. A. A., Prizão, V. M., de Souza, M. M., Mendes, B. X., Defante, M. L. R., Martins, O. C., & Rodrigues, A. M. (2024). The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials. Journal of Diabetes and Its Complications, 38, 108834. https://doi.org/10.1016/j.jdiacomp.2024.108834